MR CLEAN is a Dutch trial that investigated treatment of a severe form of ischaemic stroke (blockage type stroke) with thrombolysis alone (dissolving a clot with clot-busting drugs), versus treatment with both thrombolysis.
As part of our research programme, we fund exceptional candidates from stroke professional backgrounds to our prestigious Postgraduate and Postdoctoral Fellowship positions. Meet our new fellows for 2017.
In a new guest blog, published on the Evidently Cochrane website, Annette shares her story of living with dysarthria after stroke. Claire Mitchell, Speech and Language Therapist and author of a newly updated Cochrane Review on dysarthria, explains the findings.
The ReTrain study is investigating the effectiveness of a community-based rehabilitation training programme for people who have suffered a stroke. Published in the journal BMJ Open, the 'study protocol' for ReTrain outlines why the study was needed, and includes the methods to be used in the study, the resources required for the study and a timeline for completion.
Cerebral small vessel disease (SVD) is usually associated with high blood pressure, and causes 20% of all strokes. It is the main cause of cognitive changes and dementia associated with stroke. Behavioural symptoms such as apathy are also common in patients with SVD.
On February 11, at the International Stroke Conference (ISC 2015 in Nashville, USA) the latest findings were released from four, large studies investigating the effect of treating patients with mechanical clot retrieval.
Improving our prediction of recovering language abilities after stroke.
The recovery of stroke survivors with language difficulties is famously variable. Some stroke survivors recover much more quickly or fully than others. Some respond to treatment much better than others.
Does fluoxetine improve recovery after stroke? Start-up phase for a large trial.